Marshall Wace, LLP
- SEC CIK
- 0001318757
- Latest filing
- Aug 13, 2026
CTIC holding history
Cti Biopharma Corp in every 13F filed by Marshall Wace, LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CTIC overviewAll 13F holders of CTICFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −5,960,103−100.0% | Sold out | Holders |
| Q1 2023 | 5,960,103 | $25.0M | 0.1% | +5,960,103 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −862,383−100.0% | Sold out | Holders |
| Q1 2022 | 862,383 | $4.03M | <0.1% | +773,293+868.0% | Added | Holders |
| Q4 2021 | 89,090 | $221.0K | <0.1% | +89,090 | New | Holders |